Skip to main content
Clinical Trials/CTRI/2024/01/061562
CTRI/2024/01/061562
Not yet recruiting
Phase 2

Efficacy of Platelet-Rich Plasma and Platelet-Rich Fibrin in Diabetic Foot Ulcer- A Randomised, parallel group active comparator trial - NI

Chahat Bansal0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications
Sponsor
Chahat Bansal
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Chahat Bansal

Eligibility Criteria

Inclusion Criteria

  • Age more than 18 years and less than 70years
  • Both male and female group
  • Documented Diagnoses of Diabetes Mellitus
  • Ulcer Characteristics
  • Ulcer size more than 0\.5cm2 and less than 20cm2
  • Ulcer site Plantar surface of foot
  • Ulcer duration more than 4 weeks
  • UTS Grade 1A 1B 1C,2A 2B or 2C
  • Ulcers with absent or mild infection according to IWGDF or IDSA grading
  • Palpable dorsalis pedis artery anterior tibial artery and posterior tibial artery or

Exclusion Criteria

  • Ulcers with moderate or severe infection according to IWGDF grading requiring active surgical debridement or intravenous antibiotics
  • Ulcers of grade 1D 2D 3A 3B 3C or 3D according to University of Texas staging for DFUs
  • Ulcers due to underlying Charcot foot
  • Ulcer on foot other than plantar surface
  • Evidence of osteomyelitis on any part of the limb
  • Evidence of gangrene on any part of the affected limb
  • Bilateral diabetic foot ulcers
  • ankle brachial index less than 0\.8 or non\-palpable ATA PTA DPA
  • haemoglobin less than 10g per dl
  • platelet count less than 150000 per dl

Outcomes

Primary Outcomes

Not specified

Similar Trials